Nasal Mucormycosis: Our experience with 24 cases

• Authors: Satvinder Singh Bakshi , Soumyajit Das , Seepana Ramesh , Suriyanarayanan Gopalakrishnan

Abstracts

EN

Background: Mucormycosis is a rare fungal infection affecting people with impaired immunity. The aim of this study is to shed light on the epidemiology, incidence, and outcome of patients with mucormycosis hospitalized at a tertiary care center in Pondicherry.
Methods: We conducted a retrospective chart review between January 2008 and January 2018. All patients with proven or probable mucormycosis were included.
Results: A total of 24 patients were included. Their median age was 49 years and the majority were males. Comorbidities included mainly hematologic malignancy and diabetes mellitus. A liposomal amphotericin B formulation alone or in combination with other antifungals was used as a first line agent in all patients.
Conclusion: The incidence of mucormycosis has significantly increased over the past 10 years at our institution, most likely due to increased risk factors.

Keywords

EN

amphotericin B; debridement; invasive fungal infection; mucormycosis; mycoses; rhinocerebral mucormycosis; zygomycosis

• Journal: Otolaryngologia Polska
• Year: 2020
• Volume: 74(4)
• Pages: 37-40

Dates

published

2020-02-20

Contributors

author

Satvinder Singh Bakshi

author

Soumyajit Das

author

Seepana Ramesh

author

Suriyanarayanan Gopalakrishnan

Identifiers

DOI

10.5604/01.3001.0013.8593